Zacks Investment Research on MSN15h
Novo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2%Novo Nordisk NVO announced an update to the savings offer for its popular obesity injection, Wegovy (semaglutide). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback